Gollob Jared

CIK 00018211981 companyWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001821198

Recent Transactions

50 trades

Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-08$88.02/sh−18,357→ 127,183 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-08$87.37/sh−13,759→ 145,540 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-08$5.33/sh+49,307→ 159,299 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-12-08−49,307→ 34,083 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-08$92.19/sh−1,400→ 109,992 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-08$91.46/sh−3,300→ 111,392 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-08$90.12/sh−8,562→ 114,692 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-08$89.43/sh−3,929→ 123,254 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-10-15−22,210→ 0 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-10-15$60.37/sh−29,264→ 140,304 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-10-15−28,999→ 0 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-10-15$62.72/sh−14,896→ 116,445 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-10-15$2.08/sh+22,210→ 169,568 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-10-15$63.09/sh−6,453→ 109,992 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-10-15$61.49/sh−8,963→ 131,341 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-10-15$1.31/sh+28,999→ 147,358 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-10-13$1.31/sh+800→ 120,800 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-10-13$2.08/sh+673→ 121,473 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-10-13−800→ 28,999 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-10-13−673→ 22,210 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-10-13$60.00/sh−3,114→ 118,359 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-03-03$30.33/sh−4,695→ 121,045 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-03-03$31.00/sh−1,045→ 120,000 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-03-03+60,000→ 60,000 total
Award
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-03-03+30,000→ 125,740 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-07-16$2.08/sh+23,145→ 118,885 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-07-16$46.10/sh−9,864→ 95,470 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-07-16$45.59/sh−13,281→ 105,604 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-07-16−23,145→ 22,883 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-07-15$2.08/sh+16,455→ 112,195 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-07-15$45.15/sh−16,455→ 95,740 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-07-15−16,455→ 46,028 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-03-04$42.39/sh−1,106→ 95,956 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-03-04$41.41/sh−2,022→ 97,062 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-03-04$43.26/sh−216→ 95,740 total
Award
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-03-01+24,375→ 99,084 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-03-01+146,250→ 146,250 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-02-27$45.00/sh−400→ 74,709 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-02-27$2.08/sh+400→ 75,109 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-02-27−400→ 62,483 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-02-09$2.08/sh+46,137→ 120,846 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-02-09$36.09/sh−7,398→ 74,709 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-02-09−46,137→ 62,883 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-02-09$35.39/sh−38,739→ 82,107 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2023-03-02$31.40/sh−297→ 74,709 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2023-03-02$30.88/sh−1,001→ 75,006 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2023-03-01+112,500→ 112,500 total
Award
Kymera Therapeutics, Inc.$KYMR
Common Stock
2023-03-01+18,750→ 76,007 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-05-04−9,792→ 109,020 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2022-05-04$2.08/sh+9,792→ 57,257 total

Companies

Kymera Therapeutics, Inc.
Chief Medical Officer
$KYMR

Recent Filings

Address

C/O KYMERA THERAPEUTICS, INC. 500 NORTH BEACON STREET, 4TH FLOOR

WATERTOWN, MA, 02472

View on SEC.gov